Metabolic interactions between mibefradil and HMG-CoA reductase inhibitors: Linking in vitro with in vivo information [1]

British Journal of Clinical Pharmacology

Volumn 49, Issue 1, 2000, Pages 87-90

  Muck, W ^a   Prueksaritanont, T ^a   Lin, L H ^a   Baillie, T A ^a  

^a BAYER AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; CERIVASTATIN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; MIBEFRADIL; SIMVASTATIN;

AREA UNDER THE CURVE; CONTROLLED STUDY; DRUG CLEARANCE; DRUG HALF LIFE; HUMAN; LETTER; PRIORITY JOURNAL;

AREA UNDER CURVE; BIOTRANSFORMATION; DRUG INTERACTIONS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MIBEFRADIL;

EID: 0033977595     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (0)